Related Experiment Video
Updated: May 29, 2025
Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods
Published on: September 10, 2016
Sleep-enhancing activity of fermented pea protein hydrolysate with enhanced GABA content by Lactobacillus brevis SYLB
Hyeon Deok Kim, Hyung Joo Suh1, Seok Hyun Chung1,2
1Department of Integrated Biomedical and Life Science, Graduate School, Korea University, Seoul, Republic of Korea.
Background:
Sleep is essential for overall health and wellbeing. This study investigated the sleep-promoting effects of fermented pea protein hydrolysate (PPF) with increased gamma-aminobutyric acid (GABA) content produced by Lactobacillus brevis SYLB 0016. The effects of PPF on sleep duration and structure were assessed in pentobarbital-induced ICR mice and Sprague Dawley (SD) rats using electroencephalogram (EEG) analysis.
Results:
Hydrolysis of pea protein with Alcalase, Protana Prime, and Protana UBoost increased the amino nitrogen content, degree of hydrolysis and glutamate content to 160.51 mmol L-1. Fermentation by Lactobacillus brevis SYLB 0016 increased the GABA content from 3.16 to 90.35 mmol L-1. PPF significantly increased sleep duration (56.3 min) compared to the normal control (30.6 min) in pentobarbital-induced sleep tests. Non-rapid eye movement (NREM) sleep time increased with a significant rise in δ-waves activity following administration of 150 mg kg-1 of PPF. In caffeine-induced insomnia, both low- and high-dose PPF significantly increased sleep duration. Three weeks of oral PPF administration elevated GABAA and GABAB receptor expression, with GABAA receptor protein levels showing a significant change. Co-administration of flumazenil with PPF reduced sleep time, indicating the involvement of the GABAA receptor benzodiazepine site in PPF's sleep-enhancing effects.
Conclusion:
In conclusion, PPF with enhanced GABA content improves NREM sleep by increasing δ waves activity. As a hypoallergenic compound, PPF holds potential as a supplement to ameliorate sleep disorders. © 2025 Society of Chemical Industry.
More Related Videos
00:06Analysis of Interactions between Endobiotics and Human Gut Microbiota Using In Vitro Bath Fermentation Systems
Published on: August 23, 2019
05:45Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality
Published on: April 7, 2023
Related Concept Videos
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
01:19Management of Insomnia
01:23Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
01:29Anxiolytic Drugs: Benzodiazepines and Buspirone
01:19Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...